LABEUROP: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LABEUROP
Largest movements
- Stocks and contracts +€8,771
up €8,771 (+28.5%), from €30,758 to €39,529
No liability line moved by more than 1% of the balance sheet total.
- Other operating charges -€387
no longer reported in 2025 (was €387)
- Gross operating margin +€193
up €193 (+10.1%), from €1,914 to €2,107
- Taxes +€125
new in 2025: €125
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €552,806 | €556,035 | +€3,229 | +0.6% |
| Fixed assets | 21/28 | €437,750 | €437,750 | = | 0.0% |
| Financial fixed assets | 28 | €437,750 | €437,750 | = | 0.0% |
| Current assets | 29/58 | €115,056 | €118,285 | +€3,229 | +2.8% |
| Stocks and contracts in progress | 3 | €30,758 | €39,529 | +€8,771 | +28.5% |
| Stocks | 30/36 | €30,758 | €39,529 | +€8,771 | +28.5% |
| Amounts receivable within one year | 40/41 | €81,040 | €76,689 | -€4,351 | -5.4% |
| Trade receivables | 40 | €36 | - | -€36 | |
| Other amounts receivable | 41 | €81,004 | €76,689 | -€4,315 | -5.3% |
| Cash at bank and in hand | 54/58 | €3,259 | €2,067 | -€1,192 | -36.6% |
| Total equity and liabilities | 10/49 | €552,806 | €556,035 | +€3,229 | +0.6% |
| Equity | 10/15 | €287,761 | €289,693 | +€1,932 | +0.7% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Capital | 10 | €75,000 | €75,000 | = | 0.0% |
| Issued capital | 100 | €75,000 | €75,000 | = | 0.0% |
| Reserves | 13 | €225,059 | €225,059 | = | 0.0% |
| Non-distributable reserves | 130/1 | €7,500 | €7,500 | = | 0.0% |
| Legal reserve | 130 | €7,500 | €7,500 | = | 0.0% |
| Distributable reserves | 133 | €217,559 | €217,559 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€12,298 | -€10,366 | +€1,932 | +15.7% |
| Amounts payable | 17/49 | €265,045 | €266,342 | +€1,297 | +0.5% |
| Amounts payable within one year | 42/48 | €265,045 | €266,255 | +€1,210 | +0.5% |
| Trade debts | 44 | €228 | €1,567 | +€1,339 | +587.1% |
| Suppliers | 440/4 | €228 | €1,567 | +€1,339 | +587.1% |
| Other amounts payable | 47/48 | €264,817 | €264,688 | -€129 | 0.0% |
| Accrued charges and deferred income | 492/3 | - | €87 | +€87 | |
| Other operating charges | 640/8 | €387 | - | -€387 | |
| Gross operating margin | 9900 | €1,914 | €2,107 | +€193 | +10.1% |
| Operating profit (loss) | 9901 | €1,526 | €2,107 | +€581 | +38.0% |
| Financial charges | 65/66B | €40 | €50 | +€10 | +25.9% |
| Recurring financial charges | 65 | €40 | €50 | +€10 | +25.9% |
| Profit (loss) for the period before taxes | 9903 | €1,487 | €2,057 | +€570 | +38.4% |
| Income taxes | 67/77 | - | €125 | +€125 | |
| Profit (loss) for the period | 9904 | €1,487 | €1,932 | +€445 | +30.0% |
| Profit (loss) for the period to be appropriated | 9905 | €1,487 | €1,932 | +€445 | +30.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.